CD Genomics provides viral genome sequencing service within Illumina and PacBio Platforms. We can create high-quality de novo assembly of large viral genomes and highest possible data quality at low cost.
The Introduction of Viral Genome Sequencing
Viruses are the most abundant biological entities on Earth and significantly impact living organisms by causing diseases and shaping their immune systems. Despite their ubiquity and influence, less than 0.01% of viruses are sequenced. Presently, the study of viral infectious diseases in terms of etiopathogenesis and development of newer therapeutics is undergoing rapid changes. One commonly used NGS platforms: Illumina, recommend maximum fragment lengths of about 300-500 nucleotides for analysis respectively. More recently sequencing technology has been improved with PacBio single-molecule real-time sequencing. Here complete long reads can be obtained with less error overcoming a limitation of the NGS.
CD genomics platform holds great potential for viral genome sequencing. Comprehensive virus sequences will facilitate interpretation of viral metagenomics data by providing reference genomes, lead to a better understanding of virus diversity, ecology, adaptation and evolution, and enable the prediction of emerging infectious diseases caused by viruses.
Key Features and Advantages
Viral DNA/cDNA amount: 1 ug
Illumina Platform, Library size: 300-500 bp, PE 250, 100X
PacBio Platform: Library size: 2 K, 1G
Viral genome sequencing is a fast and efficient method for research on viral replication, packaging, function of terminase, transcription regulation, and metabolism of host cell. CD genomics can deliver high quality sequencing data for your virus genome of interest. Contact us for assistance in configuring your project.